Merrem and Bleeding disorders - a phase IV clinical study of FDA data

Summary:

Bleeding disorders is reported as a side effect among people who take Merrem (meropenem), especially for people who are male, 10-19 old, have been taking the drug for < 1 month also take Heparin, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Bleeding disorders when taking Merrem. It is created by eHealthMe based on reports of 979 people who have side effects when taking Merrem from the FDA, and is updated regularly.

What is Merrem?

Merrem has active ingredients of meropenem. eHealthMe is studying from 996 Merrem users. Check the latest studies of Merrem.

What is Bleeding disorders?

Bleeding disorders is found to be associated with 1,194 drugs and 1,648 conditions by eHealthMe. Check the latest studies of Bleeding disorders.

On Aug, 07, 2026

979 people reported to have side effects when taking Merrem.
Among them, 11 people (1.12%) have Bleeding disorders.

Among these 11 people:

How long have people been on Merrem when they have Bleeding disorders? *

What is the gender of people who have Bleeding disorders when taking Merrem? *

female: 36.36 %
male: 63.64 %

What is the age of people who have Bleeding disorders when taking Merrem? *

What are other drugs people take besides Merrem? *

What are other side effects people have besides Bleeding disorders? *

Atelectasis (partial or complete collapse of the lung): 8 people, 72.73%
Thrombocytopenia (decrease of platelets in blood): 8 people, 72.73%
Diarrhea: 8 people, 72.73%
Pneumonia: 8 people, 72.73%
Ascites (accumulation of fluid in the abdominal cavity): 7 people, 63.64%
Fever: 7 people, 63.64%
Encephalopathy (functioning of the brain is affected by some agent or condition): 7 people, 63.64%
Confusional State: 7 people, 63.64%
White Blood Cell Count Decreased: 6 people, 54.55%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 6 people, 54.55%

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 45.45%
Pain: 3 people, 27.27%
Nausea And Vomiting: 3 people, 27.27%
Nausea (feeling of having an urge to vomit): 3 people, 27.27%
Constipation: 3 people, 27.27%
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream): 2 people, 18.18%
Stress And Anxiety: 2 people, 18.18%
Skin Disorder (skin disease): 2 people, 18.18%
Viral Infection: 2 people, 18.18%
Liver Disorder (liver diseases): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Merrem and have Bleeding disorders?

- Check whether Bleeding disorders is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Merrem:

Merrem (996 reports)

Browse all side effects of Merrem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bleeding disorders:

Bleeding disorders (1,194 drugs)

Browse all the conditions that are associated with Bleeding disorders:

Bleeding disorders (1,648 conditions)

Related publications that referenced our studies

Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on meropenem (the active ingredients of Merrem) and Merrem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.